Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.4300 (1.93%) ($12.4300 - $12.4300) on Mon. Apr. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.06% (three month average) | RSI | 73 | Latest Price | $12.4300(1.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.7% a day on average for past five trading days. | Weekly Trend | BCRX advances 8.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(39%) IWO(37%) ARKK(35%) ARKG(34%) | Factors Impacting BCRX price | BCRX will decline at least -3.53% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) TBT(-1%) TLT(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.53% (StdDev 7.06%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $11.9(4.45%) | 10 Day Moving Average | $11.39(9.13%) | 20 Day Moving Average | $10.74(15.74%) | To recent high | -8.8% | To recent low | 44.5% | Market Cap | $2.193b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |